DAGMAR ROSA-BJORKESON
CIK 1643934 · Chief Strat & Corp Dev Officer · last filed 2024-10-01
DAGMAR ROSA-BJORKESON is a Chief Strat & Corp Dev Officer who has filed 20 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing shows the insider sold $51.8K of XNCR on Oct 1, 2024. Across all open-market trades the lifetime net is −$51.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $104.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$104.7K
4
20
-$51.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XNCR | Director | 8,490 | $12.33 | $104.7K | -$51.8K | 7 | 2024-10-01 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 26,391 | $19.00 | $501.4K | $0 | 3 | 2023-05-25 |
| Keenova Therapeutics plc (MNK) Delisted | Chief Strat & Corp Dev Officer | 23,431 | $0.34 | $8.0K | $0 | 4 | 2019-06-04 |
| Baxalta Inc (BXLT) Delisted | EVP and President, Biosimilars | 71,137 | — | — | $0 | 4 | 2016-03-07 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-10-01 | XNCR | Sell (S) | −2,503 | -$51.8K | EDGAR |
| 2024-06-17 | XNCR | Grant (A) | +5,986 | $0 | EDGAR |
| 2023-11-13 | — | Mixed | −26,391 | -$501.4K | |
| 2023-06-22 | XNCR | Grant (A) | +5,007 | $0 | EDGAR |
| 2023-05-25 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +8,111 | $0 | EDGAR |
| 2022-06-27 | XNCR | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +7,737 | $0 | EDGAR |
| 2021-06-25 | XNCR | Grant (A) | — | $0 | EDGAR |
| 2021-06-01 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +10,543 | $0 | EDGAR |
| 2020-06-29 | XNCR | Grant (A) | — | $0 | EDGAR |